Where Will Morgan Stanley Stock Be in 10 Years?
Morgan Stanley (NYSE:MS) share price has been on a tear,…
Buy
60
HSIC Quote, Financials, Valuation and Earnings
Last price:
$74.80
Seasonality move
:
3.53%
Day range:
$73.45 - $74.98
52-week range:
$63.67 - $82.63
Dividend yield:
0%
P/E ratio:
30.41x
P/S ratio:
0.77x
P/B ratio:
2.64x
Volume:
2M
Avg. volume:
1.3M
1-year change:
0.2%
Market cap:
$9.3B
Revenue:
$12.3B
EPS (TTM):
$2.44
Analysts' Opinion
-
Consensus RatingHenry Schein has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 7 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $76.08, Henry Schein has an estimated upside of 2.55% from its current price of $74.19.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $55.00 representing 100% downside risk from its current price of $74.19.
Fair Value
-
According to the consensus of 11 analysts, Henry Schein has 2.55% upside to fair value with a price target of $76.08 per share.
HSIC vs. S&P 500
-
Over the past 5 trading days, Henry Schein has overperformed the S&P 500 by 3% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Henry Schein does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Henry Schein has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Henry Schein reported revenues of $3.2B.
Earnings Growth
-
Henry Schein earnings have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Henry Schein reported earnings per share of $0.78.
Enterprise value:
13.2B
EV / Invested capital:
--
Price / LTM sales:
0.77x
EV / EBIT:
25.18x
EV / Revenue:
1.06x
PEG ratio (5yr expected):
--
EV / Free cash flow:
31.46x
Price / Operating cash flow:
22.73x
Enterprise value / EBITDA:
16.25x
Gross Profit (TTM):
$3.9B
Return On Assets:
3.06%
Net Income Margin (TTM):
2.51%
Return On Equity:
6.21%
Return On Invested Capital:
4.24%
Operating Margin:
6.46%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $12.6B | $12.7B | $12.5B | $3.2B | $3.2B | |
| Gross Profit | $3.8B | $3.9B | $3.9B | $995M | $993M | |
| Operating Income | $890M | $828M | $599M | $211M | $205M | |
| EBITDA | $1.1B | $893M | $815M | $273M | $236M | |
| Diluted EPS | $4.60 | $3.38 | $2.44 | $1.05 | $0.78 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.9B | $3.9B | $4B | $4.1B | $4.1B | |
| Total Assets | $7.8B | $8.4B | $8.5B | $9.8B | $10.6B | |
| Current Liabilities | $2.6B | $2.3B | $2.1B | $2.1B | $2.9B | |
| Total Liabilities | $3.7B | $3.7B | $3.7B | $4.7B | $5.6B | |
| Total Equity | $4.1B | $4.7B | $4.8B | $5.1B | $5B | |
| Total Debt | $1.1B | $774.6M | $1B | $1.9B | $2.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $625M | $786M | $612M | $231M | $151M | |
| Cash From Investing | -$409M | -$873M | -$699M | -$468M | -$91M | |
| Cash From Financing | -$200M | $113M | $88M | $248M | -$41M | |
| Free Cash Flow | $495M | $587M | $421M | $181M | $107M | |
HSIC
Sector
Market Cap
$9.3B
$45.7M
Price % of 52-Week High
89.79%
47.48%
Dividend Yield
0%
0%
Shareholder Yield
1.47%
-0.75%
1-Year Price Total Return
0.2%
-32.34%
Beta (5-Year)
0.892
0.746
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$71.63
200-day SMA
Buy
Level
$70.52
Bollinger Bands (100)
Buy
Level
68.94 - 73.88
Chaikin Money Flow
Buy
Level
153.4M
20-day SMA
Buy
Level
$70.63
Relative Strength Index (RSI14)
Buy
Level
60.39
ADX Line
Buy
Level
18.37
Williams %R
Sell
Level
-11.0955
50-day SMA
Buy
Level
$72.20
MACD (12, 26)
Buy
Level
0.05
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
142.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.1626)
Buy
CA Score
(Annual)
Level (-0.2597)
Buy
Beneish M-Score
(Annual)
Level (-2.2728)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.6262)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
Stock Forecast FAQ
In the current month, HSIC has received 3 Buy ratings 7 Hold ratings, and 1 Sell ratings. The HSIC average analyst price target in the past 3 months is $76.08.
-
Where Will Henry Schein Stock Be In 1 Year?
According to analysts, the consensus estimate is that Henry Schein share price will rise to $76.08 per share over the next 12 months.
-
What Do Analysts Say About Henry Schein?
Analysts are divided on their view about Henry Schein share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Henry Schein is a Sell and believe this share price will drop from its current level to $55.00.
-
What Is Henry Schein's Price Target?
The price target for Henry Schein over the next 1-year time period is forecast to be $76.08 according to 11 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is HSIC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Henry Schein is a Hold. 7 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of HSIC?
You can purchase shares of Henry Schein via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Henry Schein shares.
-
What Is The Henry Schein Share Price Today?
Henry Schein was last trading at $74.80 per share. This represents the most recent stock quote for Henry Schein. Yesterday, Henry Schein closed at $74.19 per share.
-
How To Buy Henry Schein Stock Online?
In order to purchase Henry Schein stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Philip Morris Stock Overvalued?
If there is one industry that can be termed truly…
What Quantum Stocks Should I Buy?
The last several years have seen a series of tech…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
32
FTAI alert for Jan 22
FTAI Aviation [FTAI] is up 9.81% over the past day.
Sell
2
EDU alert for Jan 22
New Oriental Education & Technology Group [EDU] is down 1.13% over the past day.
Buy
51
GH alert for Jan 22
Guardant Health [GH] is up 4.5% over the past day.
